Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors

D Dumoulin; P de Goeje; M Poncin; K Bezemer; H J M Groen; E F Smit; A-M C Dingemans; A Kunert; R Hendriks; J G Aerts

doi:10.1093/annonc/mdz073.001

Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors

D Dumoulin, P de Goeje, M Poncin, K Bezemer, H J M Groen, E F Smit, A-M C Dingemans, A Kunert, R Hendriks, J G Aerts

Onderzoeksoutput › Academic

Originele taal-2	English
Pagina's (van-tot)	ii7
Aantal pagina's	1
Tijdschrift	Annals of Oncology
Volume	30
Nummer van het tijdschrift	Suppl 2
DOI's	https://doi.org/10.1093/annonc/mdz073.001
Status	Published - apr.-2019
Evenement	European Lung Cancer Congress (ELCC) - Geneva, Switzerland Duur: 10-apr.-2019 → 13-apr.-2019

Toegang tot document

10.1093/annonc/mdz073.001

Handle.net

Permanente koppeling

Document onder embargo

Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors
Final publisher's version, 97,8 KB
Kopie aanvragen

Citeer dit

Dumoulin, D., de Goeje, P., Poncin, M., Bezemer, K., Groen, H. J. M., Smit, E. F., Dingemans, A-M. C., Kunert, A., Hendriks, R., & Aerts, J. G. (2019). Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors. Annals of Oncology, 30 (Suppl 2), ii7. https://doi.org/10.1093/annonc/mdz073.001

@article{43452b8e8e544fdeafc5310298ab8133,

title = "Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors",

author = "D Dumoulin and {de Goeje}, P and M Poncin and K Bezemer and Groen, {H J M} and Smit, {E F} and Dingemans, {A-M C} and A Kunert and R Hendriks and Aerts, {J G}",

year = "2019",

month = apr,

doi = "10.1093/annonc/mdz073.001",

language = "English",

volume = "30 ",

pages = "ii7",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "Suppl 2",

note = "European Lung Cancer Congress (ELCC) ; Conference date: 10-04-2019 Through 13-04-2019",

}

Dumoulin, D, de Goeje, P, Poncin, M, Bezemer, K, Groen, HJM, Smit, EF, Dingemans, A-MC, Kunert, A, Hendriks, R & Aerts, JG 2019, 'Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors', Annals of Oncology, vol. 30 , nr. Suppl 2, blz. ii7. https://doi.org/10.1093/annonc/mdz073.001

TY - JOUR

T1 - Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors

AU - Dumoulin, D

AU - de Goeje, P

AU - Poncin, M

AU - Bezemer, K

AU - Groen, H J M

AU - Smit, E F

AU - Dingemans, A-M C

AU - Kunert, A

AU - Hendriks, R

AU - Aerts, J G

PY - 2019/4

Y1 - 2019/4

U2 - 10.1093/annonc/mdz073.001

DO - 10.1093/annonc/mdz073.001

M3 - Meeting Abstract

C2 - 32131334

VL - 30

SP - ii7

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - Suppl 2

T2 - European Lung Cancer Congress (ELCC)

Y2 - 10 April 2019 through 13 April 2019

ER -